Natascha Goedecke

Natascha Goedecke

Auto-generated profile, based on publicly available information

Natascha Goedecke

Department of Viral Immunology, Helmholtz Centre for Infection Research, Braunschweig, Germany

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 November 2020 in Science Advances
Verified
Journal Article
Open access
PDF file
Richard John Philip BrownRichard John Philip Brown
Richard John Philip Brown
BRBirthe Reinecke
Birthe Reinecke
JSJulie Sheldon
Julie Sheldon
TKTanvi Khera
Tanvi Khera
ANAnggakusuma
Anggakusuma
TPThomas Pietschmann
Thomas Pietschmann
Hepatitis C virus (HCV) has no animal reservoir, infecting only humans. To investigate species barrier determinants limiting infection of rodents, murine liver complementary DNA library screening was performed, identifying transmembrane proteins Cd302 and Cr1l as potent restrictors of HCV propagation. Combined ectopic expression in human hepatoma cells impeded HCV uptake and cooperatively mediated transcriptional dysregulation of a noncanonical program of immunity genes. Murine hepatocyte expression of both factors was constitutive and not interferon inducible, while differences in liver expression and the ability to restrict HCV were observed between the murine orthologs and their human counterparts. Genetic ablation of endogenous Cd302 expression in human HCV entry factor transgenic mice increased hepatocyte permissiveness for an adapted HCV strain and dysregulated expression of metabolic process and host defense genes. These findings highlight human-mouse differences in liver-intrinsic antiviral immunity and facilitate the development of next-generation murine models for preclinical testing of HCV vaccine candidates.

29 May 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
KSKatarzyna M. Sitnik
Katarzyna M. Sitnik
FKFran Krstanović
Fran Krstanović
NGNatascha Gödecke
Natascha Gödecke
URUlfert Rand
Ulfert Rand
TKTobias Kubsch
Tobias Kubsch
LCLuka Cicin-Sain
Luka Cicin-Sain
To date, no herpesvirus has been shown to latently persist in fibroblastic cells. Here, we show that murine cytomegalovirus, a β-herpesvirus, persists for the long term and across organs in PDGFRα-positive fibroblastic cells, with similar or higher genome loads than in the previously known sites of murine cytomegalovirus latency. Whereas murine cytomegalovirus gene transcription in PDGFRα-positive fibroblastic cells is almost completely silenced at 5 months post-infection, these cells give rise to reactivated virus ex vivo, arguing that they support latent murine cytomegalovirus infection. Notably, PDGFRα-positive fibroblastic cells also support productive virus replication during primary murine cytomegalovirus infection. Mechanistically, Stat1-deficiency promotes lytic infection but abolishes latent persistence of murine cytomegalovirus in PDGFRα-positive fibroblastic cells in vivo. In sum, fibroblastic cells have a dual role as a site of lytic murine cytomegalovirus replication and a reservoir of latent murine cytomegalovirus in vivo and STAT1 is required for murine cytomegalovirus latent persistence in vivo.